Related Experiment Video
Updated: Feb 11, 2026

P50 Sensory Gating in Infants
Published on: December 26, 2013
Parechovirus: an important emerging infection in young infants
Philip N Britton1, Cheryl A Jones2, Kristine Macartney3
1University of Sydney, Sydney, NSW allen.cheng@monash.edu.
Insights
Human parechovirus (HPeV) causes mild to severe illness in infants, with epidemics occurring regularly. Early molecular testing is crucial for diagnosis and supportive care in young children with characteristic symptoms.
Area of Science:
- Pediatrics
- Virology
- Infectious Diseases
Background:
- Human parechovirus (HPeV) causes recurrent epidemics in young children in Australia.
- HPeV genotype 3 was responsible for the late 2017 to early 2018 epidemic.
- Most infections are mild, presenting as gastroenteritis or influenza-like illness.
Purpose of the Study:
- To outline the clinical presentations and diagnostic indications for HPeV in young children.
- To emphasize the importance of molecular testing in infants with specific symptoms.
- To inform healthcare providers about management and potential long-term outcomes.
Main Methods:
- Retrospective analysis of HPeV epidemic data.
- Review of clinical presentations and diagnostic criteria for HPeV infection.
- Summary of current treatment strategies and neurodevelopmental follow-up recommendations.
Main Results:
- HPeV epidemics occur biennially in Australia, with genotype 3 prominent in 2017-2018.
- Characteristic symptoms in infants include fever, irritability, and rash; severe cases involve meningoencephalitis, seizures, or sepsis.
- Molecular testing is recommended for infants under 6 months with unexplained febrile illness, sepsis syndromes, or suspected meningoencephalitis.
Conclusions:
- Early molecular detection of HPeV is vital for appropriate management in infants.
- Supportive care is the mainstay of treatment, as no antiviral therapies exist.
- Severe HPeV infections can lead to adverse neurodevelopmental outcomes, necessitating pediatric follow-up.
Abstract:
Epidemics of human parechovirus (HPeV) causing disease in young children have occurred every 2 years in Australia since 2013. HPeV genotype 3 caused the epidemic from late 2017 to early 2018. Most HPeV infections cause no or mild symptoms including gastroenteritis or influenza-like illness. Characteristically, young infants present with fever, irritability and on occasions a diffuse rash ("red, hot and angry" babies). Severe disease can manifest as meningoencephalitis, seizures or sepsis-like presentations (including septic shock), or less common presentations including signs of surgical abdomen. Testing for HPeV by specific molecular tests is indicated in children younger than 6 months of age with characteristic presentations without another confirmed diagnosis including febrile illnesses with other suggestive features (eg, rash, seizures), sepsis syndromes (including shock), and suspected meningoencephalitis (which may be detected by magnetic resonance imaging only). There are no effective antiviral therapies. Treatment is primarily supportive, including management of complications. Some infants with severe HPeV infection may have adverse neurodevelopment. Follow-up by a paediatrician is recommended.
Related Concept Videos
Emerging Adulthood
Introduction Cardiac Emergencies
Drug Dosing: Infants and Children
Applications of GIS: Disaster Management and Emergency Response
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Stages of Infection

